DGAP-News: Burcon NutraScience Corp.: Burcon Granted Second U.S. CLARISOY Patent
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: Burcon Granted Second U.S. CLARISOY Patent
05.04.2013 / 11:30
---------------------------------------------------------------------
Burcon Granted Second U.S. CLARISOY Patent
Vancouver, British Columbia, April 4, 2013- Burcon NutraScience Corporation
(TSX :BU, NASDAQ:BUR), a leader in functional, renewable plant proteins,
has been awarded U.S. patent No. 8,404,299 for a patent covering a process
for the production of CLARISOY(TM) soy protein that is soluble in an acidic
medium, and produces transparent, heat stable solutions suitable for
protein fortification of sports drinks and other beverages.
This marks the second U.S. CLARISOY patent awarded to Burcon in the last
two months. The previously announced notice of allowance has also now
officially granted as U.S. Patent No. 8,389,040.
'We are encouraged to have a second U.S. patent grant so soon after
obtaining our first,' said Johann F. Tergesen, Burcon's president and COO.
'Our patent strategy is being rewarded with positive results, strengthening
our already broad intellectual property portfolio. CLARISOY soy protein is
the world's only plant-based protein capable of offering both clarity and
high-quality protein nutrition in low pH beverages, like sports drinks and
juices. CLARISOY's unique functional and nutritional attributes are what
drive its strong commercial value.'
Burcon's patent portfolio now consists of 224 issued patents in various
countries, including 38 in the U.S., as well as more than 400 active patent
applications, including 81 additional U.S. patent applications.
About CLARISOY Soy Protein
CLARISOY soy protein is the world's only vegetable-based protein capable of
offering both clarity and high-quality protein nutrition in low pH beverage
systems.
CLARISOY is currently under license to ADM, which offers a range of
products for both low and neutral pH applications, allowing food and
beverage companies to easily include up to 10 grams of CLARISOY per 500mL
serving.
CLARISOY 100 is a premier vegetable-based protein that offers both clarity
and high-quality protein nutrition for beverages with a pH of less than 4.
Extremely heat stable, CLARISOY 100 requires no homogenization or
stabilizers in low pH beverages.
CLARISOY 150 is a revolutionary soy protein for neutral pH beverages and
low pH beverages with cloud systems. The clean flavor and smooth mouth-feel
makes CLARISOY 150 a formulator's ideal protein ingredient.
For more information about CLARISOY, visit www.clarisoy.com
About Burcon NutraScience Corporation
Burcon NutraScience is a leader in nutrition, health and wellness in the
field of functional plant proteins. The company has developed a portfolio
of composition, application, and process patents originating from a core
protein extraction and purification technology. Burcon has developed:
CLARISOY(TM) soy protein - now licensed to Archer Daniels Midland Company -
which offers clarity and high-quality protein nutrition for low pH beverage
systems and exceptionally clean flavor at any pH; Peazazz(TM) a uniquely
soluble and clean-tasting pea protein; and Puratein(R), Supertein(TM) and
Nutratein(TM) are canola protein isolates with unique functional and
nutritional attributes. For more information about the company, visit
www.burcon.ca
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking statements. All statements
other than statements of historical fact included in this release are
forward-looking statements, including, without limitation, statements
regarding plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release. There can be no assurance that such statements will prove to
be accurate and actual results and future events could differ materially
from those anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon's plans
and expectations include the actual results of marketing activities,
adverse general economic, market or business conditions, regulatory changes
and other risks and factors detailed herein and from time to time in the
filings made by Burcon with securities regulators and stock exchanges,
including in the section entitled 'Risk Factors' in Burcon's annual
information form dated June 25, 2012. Any forward-looking statement or
information only speaks as of the date on which it was made and, except as
may be required by applicable securities laws, Burcon disclaims any intent
or obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance and accordingly undue reliance should not be put on such.
Media&Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896
(888) 408-7960 toll-free
mkirwan(at)burcon.ca www.burcon.ca
Investor Relations Contact:
John MacLennan
Managing Director
Tel (416) 644.8688
john(at)liolios.com
End of Corporate News
---------------------------------------------------------------------
05.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
206134 05.04.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.04.2013 - 11:30 Uhr
Sprache: Deutsch
News-ID 246263
Anzahl Zeichen: 7873
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 216 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: Burcon Granted Second U.S. CLARISOY Patent"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
